 Miramar, Florida -- Altor BioScience has garnered $1 million in new investment, according to an SEC regulatory filing.
Altor has created a number of proprietary treatments and platforms that assist in the treatment of cancer, viral infections and autoimmune diseases.
Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.
Altor is backed by Sanderling Ventures and other undisclosed investors. |